Healthcare & Medical Devices Global On demand · 24-48h

Global Infrared Vein Imaging Device Market Strategic Research Report

Global Infrared Vein Imaging Device Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Infrared Vein Imaging Device Market
$1362025
6.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Handheld, Desktop

By Application: Hospitals, Clinics and Rehabilitation Centers, Blood Donation Centers

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Koninklijke Philips N.V., Vivolight, AimVein, Christie Medical, BLZ Technology, SIFSOF, Qualmedi, Novarix, B. Braun Melsungen AG, Medcaptain, AccuVein, TransLite

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 110 pages
Market size 2025
$136
Million USD
Forecast CAGR
6.3%
2025-2032
Forecast 2032
$208.6
Projected
リージョン
5
Asia Pacific · Latin America · MEA · Europe · North America

概観

Scope of the Report

The global Infrared Vein Imaging Device market size is predicted to grow from US$ 136 million in 2025 to US$ 208 million in 2032; it is expected to grow at a CAGR of 6.3% from 2026 to 2032.

In 2025, global Infrared Vein Imaging Device production reached approximately 2.78 million units, with an average global market price of around US$50 per unit. In 2025, the global's total production capacity of Infrared Vein Imaging Device reached 3.47 million units. The industry average gross profit margin of this product reached 37%.An infrared vein imaging device is a medical auxiliary device that uses near-infrared light imaging technology to display the distribution of subcutaneous veins in the human body in real time. Its core working principle is based on the difference in absorption of specific wavelengths of near-infrared light between deoxygenated hemoglobin in the blood and surrounding tissues. The device illuminates the skin with an infrared light source, and the image sensor receives the information. After analysis by an internal image processing chip, a clear outline of the veins is projected onto the skin surface or displayed on a screen in real time. This process is contactless and radiation-free, effectively assisting medical personnel in quickly and accurately locating veins in patients with difficult venous punctures, such as infants, obese individuals, those with edema, or those undergoing long-term chemotherapy. This significantly improves the success rate of first-time punctures and reduces patient suffering and medical disputes.

The infrared vein imaging device industry chain is clear. The upstream mainly consists of core component suppliers, providing near-infrared light sources, image sensors, optical lenses, image processing chips, and micro-projection modules. The midstream comprises various equipment manufacturers responsible for the research, development, integration, and production of the complete device. The industry concentration is relatively dispersed. Downstream applications cover hospitals, clinics, rehabilitation centers, blood donation institutions, and academic research units at all levels, ultimately serving clinical needs such as intravenous puncture.

This industry boasts a broad market prospect and clear growth momentum. The global market size continues to expand and is expected to maintain steady growth in the coming years. The core driving force comes from the clinical needs brought about by the aging global population and the increase in chronic diseases, as well as the healthcare industry's relentless pursuit of improving patient safety and experience. Future development trends show three main directions: first, technological intelligence and integration, combining with augmented reality (AR) and artificial intelligence (AI) to achieve more intelligent vascular recognition and pathway planning; second, device portability and widespread adoption, with handheld devices rapidly penetrating primary care clinics, home care, and telemedicine scenarios due to their flexibility and low cost; and third, diversified application scenarios, gradually expanding from basic intravenous puncture assistance to more professional fields such as varicose vein surgery and cosmetic minimally invasive procedures.

Global key Infrared Vein Imaging Device players cover Koninklijke Philips N.V., Vivolight, AimVein, Christie Medical, BLZ Technology, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Infrared Vein Imaging Device market?

What factors are driving Infrared Vein Imaging Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Infrared Vein Imaging Device market opportunities vary by end market size?

How does Infrared Vein Imaging Device break out by Type, by Application?

This report presents a comprehensive overview of the global Infrared Vein Imaging Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Handheld
  • Desktop

Segment by Imaging Display Method

  • Non-display Type
  • Display Type

Segment by Application

  • Hospitals
  • Clinics and Rehabilitation Centers
  • Blood Donation Centers

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Infrared Vein Imaging Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Clinics and Rehabilitation Centers, Blood Donation Centers evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Infrared Vein Imaging Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$136
2025
Forecast
$208.6
2032
CAGR
6.3%
2025–2032
リージョン
5
global
Key companies
Koninklijke Philips N.V.VivolightAimVeinChristie MedicalBLZ TechnologySIFSOFQualmediNovarix
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
HandheldDesktop
By Application
HospitalsClinics and Rehabilitation CentersBlood Donation Centers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Handheld
  • 3.1.3 Desktop
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Clinics and Rehabilitation Centers
  • 4.1.4 Blood Donation Centers
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Koninklijke Philips N.V.
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Vivolight
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 AimVein
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Christie Medical
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 BLZ Technology
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 SIFSOF
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Qualmedi
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Novarix
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 B. Braun Melsungen AG
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Medcaptain
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 AccuVein
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 TransLite
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Infrared Vein Imaging Device market?
The global Infrared Vein Imaging Device market is estimated at US$ 136 million in 2025 (base year) and is projected to reach US$ 208 million by 2032.
How fast is the Infrared Vein Imaging Device market expected to grow?
The market is expected to grow at a CAGR of 6.3% from 2026 to 2032, expanding from US$ 136 million in 2025 to US$ 208 million in 2032, roughly 1.5 times its base-year value.
What does the Infrared Vein Imaging Device market cover?
In 2025, global Infrared Vein Imaging Device production reached approximately 2.78 million units, with an average global market price of around US$50 per unit. In 2025, the global's total production capacity of Infrared Vein Imaging Device reached 3.47 million units. The industry average gross profit margin of this product reached 37%.An infrared vein imaging device is a medical auxiliary device that uses near-infrared light imaging technology to display the distribution of subcutaneous veins in the human body in real time.
How is the Infrared Vein Imaging Device market segmented by type?
By type, the market is segmented into Handheld and Desktop.
What are the key applications of Infrared Vein Imaging Device?
Key applications covered include Hospitals, Clinics and Rehabilitation Centers and Blood Donation Centers.
Which companies are profiled in the Infrared Vein Imaging Device market report?
Key players profiled include Koninklijke Philips N.V., Vivolight, AimVein, Christie Medical, BLZ Technology, SIFSOF, Qualmedi and Novarix, among 12 companies covered in total.
What geographies does the Infrared Vein Imaging Device market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Infrared Vein Imaging Device?
The core driving force comes from the clinical needs brought about by the aging global population and the increase in chronic diseases, as well as the healthcare industry's relentless pursuit of improving patient safety and experience.
Who should buy the Infrared Vein Imaging Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Clinics and Rehabilitation Centers and Blood Donation Centers, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Infrared Vein Imaging Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.